Labastilla, Alfredo .

HRN: 26-36-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
CEFTRIAXONE 1G (VIAL)
11/18/2025
11/24/2025
IV
2g
Od
CAP-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines